The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bayer
Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC).
 
Anthony B. El-Khoueiry
Honoraria - ABL bio; Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche/Genentech
Consulting or Advisory Role - ABL Bio; Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Merck
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb; Lilly
Consulting or Advisory Role - Array BioPharma; Bayer; Bristol-Myers Squibb; Lilly
Speakers' Bureau - Lilly
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst)
 
William Proctor Harris
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Exelixis; Neo Therma; QED therapeutics; Zymeworks
Research Funding - Agios (Inst); ArQule (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); BTG (Inst); Exelixis (Inst); Halozyme (Inst); MedImmune (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Eisai
 
Max W. Sung
Consulting or Advisory Role - Eisai; Genentech
 
Dirk Waldschmidt
Speakers' Bureau - AstraZeneca; Baxalta/Shire; Bristol-Myers Squibb; Celgene; Eisai; Falk Pharma; Incyte; Ipsen; Novartis; Roche Pharma AG; Servier; Sirtex Medical
Research Funding - Servier (Inst)
Travel, Accommodations, Expenses - Bayer; Celgene; Ipsen; Novartis; Sirtex Medical
 
Roniel Cabrera
Research Funding - Bayer (Inst)
 
Vittorio Luigi Garosi
Employment - Bayer
 
Hong Zebger-Gong
No Relationships to Disclose
 
Barbara J. Brennan
Employment - Bayer
Stock and Other Ownership Interests - Bayer; Roche
Consulting or Advisory Role - Roche (I)
 
Ying A. Wang
Employment - Bayer
Stock and Other Ownership Interests - Bayer; Forma Therapeutics (I); Novartis
 
Udo Mueller
Employment - ClinStat
Consulting or Advisory Role - Bayer (Inst)
 
Tatiane Cristine Ishida
Employment - Bayer
 
Peter R. Galle
Honoraria - Adaptimmune; Bayer Schering Pharma; Bristol-Myers Squibb; Ipsen; Lilly; MSD; Roche/Genentech; Sirtex Medical
Consulting or Advisory Role - Adaptimmune; Bayer Schering Pharma; Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech; Sirtex Medical
Speakers' Bureau - Bayer Schering Pharma; Ipsen; Lilly; Roche
Travel, Accommodations, Expenses - Bayer Schering Pharma; Lilly; Sirtex Medical